# Delivery of siRNA to the Eye: Protocol for a Feasibility Study to Assess Novel Delivery System for Topical Delivery of siRNA Therapeutics to the Ocular Surface

Paulina Baran-Rachwalska Suzanne Saffie-Siebert and C. B. Tara Moore

## Abstract

Drug delivery to the eye remains a real challenge due to the presence of ocular anatomical barriers and physiological protective mechanisms. The lack of effective siRNA delivery mechanism has hampered the real potential of RNAi therapy, but recent literature suggests that nanocarrier systems show great promise in enhancing siRNA bioavailability and reducing the need for repeated intraocular injections. A diverse range of materials are under exploration worldwide, including natural and synthetic polymers, liposomes, peptides, and dendrimeric nanomaterials. This chapter describes a simple workflow for feasibility assessment of a proposed ocular surface siRNA delivery system. Gel retardation assay is used for investigation of optimal siRNA to carrier loading ratio. Fluorescent siRNA allows for initial in vitro testing of cellular uptake to corneal epithelial cells and investigation of in vivo siRNA delivery into mouse cornea by live animal imaging and fluorescence microscopy.

<span style=color:blue>眼部药物递送依然面临巨大挑战，因为眼睛具有解剖屏障和生理保护机制。有效的siRNA递送机制的缺乏限制了RNA干扰（RNAi）疗法的潜力，但近期的研究表明，纳米载体系统在提高siRNA生物利用度和减少需要反复眼内注射方面展现出了极大的前景。目前，全球范围内正在探索多种不同的材料，包括天然和合成聚合物、脂质体、肽类及树枝状纳米材料。本章介绍了评估拟议眼表siRNA递送系统可行性的简易工作流程。首先通过凝胶滞留实验来确定siRNA与载体的最佳负载比。使用荧光标记的siRNA进行初步的体外实验，以测试角膜上皮细胞的细胞摄取情况，并通过活体成像和荧光显微镜观察siRNA在小鼠角膜中的体内递送效果。</span>

## 1 Introduction 前言

The eye is a particularly attractive target for developing innovative therapies due to its small size and external accessibility for local drug treatment. Moreover, it is quite isolated from the rest of the body, limiting the access of the drug administered into this organ to systemic circulation and minimalizing the risk of possible off-target effects. However, most drugs exhibit difficulties for overcoming the eye-associated barriers, and a delivery of large hydrophilic charged siRNA molecules is particularly challenging. While eye tissues are accessible by injection, it is a very delicate administration route and a noninvasive topical administration is considered preferable, especially for siRNA therapeutics with short in vivo half-life which requires repeated treatment regimen to achieve a continuous ocular presence of intact nucleic acid. However, the ocular surface is a complex biological barrier that has proven challenging for topical drug delivery due to the combined effect of short contact time, the presence of tear film, and the barrier properties of the cornea.

<span style=color:blue>眼睛因其体积小且可以通过外部访问，非常适合开发创新疗法，尤其适用于局部药物治疗。更重要的是，眼睛与身体其他部位相对隔离，限制了药物进入眼睛后进入全身循环的机会，从而降低了非靶向效应的风险。然而，大多数药物在突破眼部屏障时面临诸多困难，尤其是对于大分子、亲水性和带电的siRNA分子。尽管眼部组织可通过注射进行给药，这是一种非常精细的给药方式，但考虑到安全性和便利性，非侵入性的局部给药更为理想，尤其对于那些半衰期较短、需要重复治疗以确保核酸在眼部持续存在的siRNA疗法。然而，眼表是一个复杂的生物屏障，由于接触时间短、泪膜存在以及角膜的屏障作用，局部药物递送一直面临挑战。</span>

Designing a drug delivery system for topical ocular administration effective in siRNA delivery to the eye is a major challenge for scientists developing RNAi therapies. Broad delivery strategies and a wide range of materials are under exploration worldwide, including natural and synthetic polymers, liposomes, peptides, and dendrimeric nanomaterials. Drug-loading capacity, release rate, and ocular retention time of drug delivery systems would have a great impact on the bioavailability of siRNA at the target site. Herein we describe an easy approach to test the potential of a new carrier system being engineered for topical delivery of siRNA to the cornea . The methodology described could be also adapted for evaluation of siRNA delivery system developed for other anterior or posterior eye tissues.

<span style=color:blue>设计一种有效的局部给药系统，特别是针对siRNA的眼部递送，已成为RNAi疗法开发中的一个重大挑战。全球范围内，研究人员正在探索多种递送策略和材料，包括天然和合成聚合物、脂质体、肽类及树枝状纳米材料。药物的载荷能力、释放速率及眼部滞留时间等因素将直接影响siRNA在靶向部位的生物利用度。本文介绍了一种简单的方法，用于评估一种新型载体系统在局部递送siRNA到角膜中的潜力。该方法也可适用于评估其他眼前或眼后组织的siRNA递送系统。</span>

Commonly used gel retardation assay, also known as gel shift assay, has been adapted to investigate siRNA entrapment by a delivery system and optimize the siRNA loading ratio. The electrophoretic separation of complexes formed with various increasing weight ratios of carrier to siRNA allows to quickly determine if the carrier is capable of binding to a given RNA duplex and identify the optimal loading conditions for the most effective siRNA entrapment.

<span style=color:blue>常见的凝胶延迟实验（或称为凝胶迁移实验）已被应用于研究siRNA在递送系统中的包封情况，并优化siRNA的载荷比。通过对不同载体与siRNA重量比的复合物进行电泳分离，可以迅速判断载体是否能够与特定的RNA双链结合，并确定最适合的siRNA载荷条件，以实现最佳的捕获效果。</span>

An efficient internalization of siRNA is a matter of great importance for topical ophthalmic RNAi drug delivery; therefore we present a protocol for testing cellular uptake using commercial siGLO marker. This fluorescently tagged siRNA enables visual assessment of uptake into cornea cells in vitro as well as in vivo imaging. Topical delivery of labeled siRNA into mouse cornea can be assessed by live animal imaging using IVIS Spectrum and further evaluated in eye sections with fluorescence microscopy. Two variants of siGLO transfection indicator are available; however due to distinct spectral properties of green and red fluorophores, performance may differ based on the delivery and detection methods employed. As per manufacturer’s recommendations, siGLO Green (FAM-labeled) represents the ideal choice for studying cellular uptake by microscopy or flow cytometry following in vitro transfection, whereas siGLO Red (tagged with DY-547), which exhibits a stronger signal at lower concentrations, would be a better selection for in vivo imaging.

<span style=color:blue>siRNA的高效内化是局部眼科RNAi药物递送的关键问题，因此我们提供了一种使用商业siGLO标记物来测试细胞内化的实验方法。该荧光标记的siRNA使得我们能够直观地评估siRNA在体外角膜细胞的摄取情况，并通过体内成像观察其在小鼠角膜中的递送情况。通过使用IVIS Spectrum进行活体成像，可以实时跟踪标记siRNA在小鼠眼部的递送，进一步通过荧光显微镜在眼组织切片中评估递送效果。siGLO转染指示剂有两种不同的变体可供选择，鉴于绿色和红色荧光团的光谱特性不同，基于所采用的递送和检测方法，其表现可能有所差异。根据制造商的推荐，siGLO Green（FAM标记）是研究体外转染后细胞内化的理想选择，适合使用显微镜或流式细胞术进行分析；而siGLO Red（标记为DY-547），因其在低浓度下发出更强的信号，更适合用于体内成像。</span>

## 2 Materials 材料

### 2.1 Gel Retardation Assay 凝胶延迟试验

1. Tested carrier system , suspended in nuclease-free water or buffer to form stable solution.<span style=color:blue>将测试的载体系统悬浮在无核酸酶的水或缓冲液中，形成稳定的溶液。</span>
2. Chosen siRNA oligonucleotide, diluted with nuclease-free water to 5 μM concentration. <span style=color:blue>将选择的siRNA寡核苷酸用无核酸酶水稀释至5 μM浓度。</span>
3. Agarose gel: agarose, 10× TBE (Tris-Borate-EDTA) buffer, GelRed® Nucleic Acid Stain 10,000×, distilled water. <span style=color:blue>琼脂糖凝胶：琼脂糖、10× TBE（Tris-Borate-EDTA）缓冲液、GelRed® 核酸染料（10,000×浓缩液）、蒸馏水。</span>
4. Gel imager (a standard UV transilluminator or gel documentation system). <span style=color:blue>凝胶成像仪（常规紫外线透照仪或凝胶成像系统）。</span>

### 2.2 Human Corneal Epithelium (HCE) Cell Line Maintenance 人类角膜上皮（HCE）细胞系的培养

1. HCE cells. <span style=color:blue>HCE细胞</span>
2. DMEM low glucose with GlutaMAX™ supplement. <span style=color:blue>含GlutaMAX™补充剂的低葡萄糖DMEM培养基</span>
3. Fetal bovine serum. <span style=color:blue>胎牛血清</span>
4. Trypsin/EDTA (0.25%). <span style=color:blue>胰蛋白酶/EDTA（0.25%）</span>
5. Phosphate-buffered saline.<span style=color:blue>磷酸盐缓冲液</span>

### 2.3 In Vitro Cellular Uptake of Fluorescent siRNA to Corneal Epithelial Cells 体外荧光siRNA在角膜上皮细胞中的摄取

1. Tested carrier system, suspended in nuclease-free water or buffer to form stable solution. <span style=color:blue>将测试的载体系统悬浮在无核酸酶的水或缓冲液中，形成稳定溶液</span>
2. Fluorescent siRNA marker : siGLO Green Transfection Indicator (Dharmacon). <span style=color:blue>使用荧光标记的siRNA标记物：siGLO Green转染指示剂（Dharmacon）</span>
3. HCE cells. <span style=color:blue>HCE细胞</span>
4. DMEM low glucose with GlutaMAX™ supplement. <span style=color:blue>含GlutaMAX™补充剂的低葡萄糖DMEM培养基</span>
5. Fetal bovine serum. <span style=color:blue>胎牛血清</span>
6. Trypsin/EDTA (0.25%). <span style=color:blue>胰蛋白酶/EDTA（0.25%）</span>
7. Phosphate-buffered saline. <span style=color:blue>磷酸盐缓冲液</span>
8. OptiMEM. <span style=color:blue>OptiMEM培养基</span>
9. 24-Well plate. <span style=color:blue>24孔板</span>
10. 13 mm Coverslips and microscope slides. <span style=color:blue>13 mm的盖玻片和显微镜载玻片</span>
11. 4% Paraformaldehyde solution in PBS. <span style=color:blue>4%多聚甲醛溶液（PBS中）</span>
12. Aqueous mounting medium with DAPI. <span style=color:blue>含DAPI的水性封片介质</span>
13. Zeiss Axio Scope A1 fluorescence microscope equipped with DAPI and FITC filter. <span style=color:blue>配有DAPI和FITC滤光片的Zeiss Axio Scope A1荧光显微镜</span>

### 2.4 In Vivo siRNA Uptake into Mouse Cornea siRNA在小鼠角膜中的体内摄取

1. Tested carrier system, suspended in nuclease-free water or buffer to form stable solution. <span style=color:blue>将测试的载体系统悬浮在无核酸酶的水或缓冲液中，形成稳定溶液</span>
2. Fluorescent siRNA marker : siGLO Red Transfection Indicator (Dharmacon). <span style=color:blue>使用荧光标记的siRNA标记物：siGLO Red转染指示剂（Dharmacon）</span>
3. Wild-type adult mice. <span style=color:blue>野生型成年小鼠</span>
4. IVIS Spectrum system with LivingImage software. <span style=color:blue>配有LivingImage软件的IVIS Spectrum系统</span>
5. Isoflurane. <span style=color:blue>异氟烷</span>
6. Phosphate-buffered saline. <span style=color:blue>磷酸盐缓冲液</span>
7. 4% Paraformaldehyde <span style=color:blue>4%多聚甲醛溶液</span>
8. PolyFreeze embedding medium. <span style=color:blue>PolyFreeze包埋介质</span>
9. Dry ice. <span style=color:blue>干冰</span>
10. Isopentane. <span style=color:blue>异戊烷</span>
11. Cryostat. <span style=color:blue>冷冻切片机</span>
12. Microscope slides and coverslips. <span style=color:blue>显微镜载玻片和盖玻片</span>
13. Aqueous mounting medium with DAPI. <span style=color:blue>含DAPI的水性封片介质</span>
14. Zeiss Axio Scope A1 fluorescence microscope equipped with DAPI and Cy5 filter. <span style=color:blue>配有DAPI和Cy5滤光片的Zeiss Axio Scope A1荧光显微镜</span>

## 3 Methods 方法

### 3.1 Gel Retardation Assay

1. To prepare 1% agarose gel , dissolve 0.5 g of agarose in 50 mL 0.5× TBE by warming the solution in the microwave. Allow the dissolved gel solution to cool and add 5 μL GelRed® Nucleic Acid Stain. Pour the gel in appropriate tray with well combs inserted and allow it to solidify (*see* **Note** **1**). <span style=color:blue>准备1%的琼脂糖凝胶，将0.5克琼脂糖溶解在50毫升0.5× TBE缓冲液中，通过微波加热溶解。溶解后冷却，加入5μL的GelRed®核酸染料。将凝胶倒入适当的托盘中，插入凝胶梳并等待凝固（*参见* **注释1**）。</span>
2. Prepare tested samples of siRNA-carrier formulation at increasing loading ratio (*see* **Note** **2**) in a total volume of 8 μL and an equal final siRNA concentration of 1.25 μM, as described in Table 1. Incubate samples at room temperature for 30 min or according to previously optimized conditions (*see* **Note** **3**). <span style=color:blue>准备测试的siRNA-载体配方样品，按递增的载体与siRNA比率（*参见* **注释2**），将总量设置为8μL，最终siRNA浓度为1.25μM，按照表[1]()的说明。将样品在室温下孵育30分钟，或根据已优化的条件进行孵育（*参见* **注释3**）。</span>
3. Add 2 μL of 5× loading dye to each sample and mix by pipetting. <span style=color:blue>向每个样品中加入2μL的5×加载染料，并通过移液器混匀。</span>
4. Place the agarose gel in a tank filled with 0.5× TBE buffer, remove the comb, and load the samples to the gel wells (10 μL per lane).<span style=color:blue>将琼脂糖凝胶放入充满0.5× TBE缓冲液的泳道箱中，去除凝胶梳，向凝胶孔中加载样品（每条泳道10μL）。</span>
5. Run electrophoresis at constant 100 mA for about 40 min (at that point siRNA band should be at about ¾ of a 5 cm gel).在100 mA的电流下进行电泳约40分钟，直到siRNA带移至5厘米凝胶的约3/4处。</span>
6. Visualize the gel under the UV gel imager . An example of gel imaging output is shown in Fig. 1.<span style=color:blue>在紫外线凝胶成像仪下观察凝胶并记录成像结果，示例结果见图1。</span>

**Table 1** Guidance for preparation of siRNA-carrier formulation samples at increasing loading ratio for gel retardation assay

| Sample ID | Loading ratio (*v/v*)carrier to siRNA | Mixing ratio (volume) [μL] |      |      |      |
| :-------- | :------------------------------------ | :------------------------- | ---- | ---- | ---- |
| siRNA5 μM | Carrier                               | Water                      |      |      |      |
| 1         | Control                               | 0: 2                       | 2 μL | –    | 6 μL |
| 2         | Sample L0.5                           | 1: 2                       | 2 μL | 1 μL | 5 μL |
| 3         | Sample L1                             | 2: 2                       | 2 μL | 2 μL | 4 μL |
| 4         | Sample L2                             | 4: 2                       | 2 μL | 4 μL | 2 μL |
| 5         | Sample L3                             | 6: 2                       | 2 μL | 6 μL | –    |

![485053_1_En_24_Fig1_HTML](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_24_Fig1_HTML.png)

**Fig. 1** Gel retardation assay for optimization of carrier to siRNA ratio. The electrophoretic separation of a carrier-siRNA mixture on agarose gel reflects the fraction of free and complexed siRNA. The unbound siRNA migrates through the gel and shows a band corresponding to free siRNA control (line 1), while the siRNA bound by a carrier system remains immobilized within the wells (line 2–5). The intensity of unbound siRNA band decreases and the intensity of bound siRNA increases with the increasing carrier to siRNA ratio

### 3.2 Human Corneal Epithelium (HCE) Cell Line Maintenance

1. HCE cells are cultured in a standard 1× Dulbecco’s modified eagle medium (DMEM) supplemented with GlutaMAX™ and 10% heat-inactivated fetal bovine serum (FBS) in an incubator at 37 °C with 5% CO<sub>2</sub>. Sub-confluent cultures (70–80%) are split at 1:2–1:4 ratio as described below.<span style=color:blue>将HCE细胞培养在标准的1×杜氏改良鹰培养基（DMEM）中，加入GlutaMAX™和10%的热灭活胎牛血清（FBS），并放置于37°C、5% CO2的培养箱中。当细胞生长达到70–80%的融合度时，按照1:2或1:4的比例分割培养。</span>
2. Remove and discard the growth medium. <span style=color:blue>移除并丢弃旧的培养基。</span>
3. Gently rinse the cell layer with 3 mL phosphate-buffered saline. Aspire and discard the wash solution.<span style=color:blue>用3毫升磷酸盐缓冲液轻轻冲洗细胞层，吸取并丢弃洗涤液。</span>
4. Add the pre-warmed 1× Trypsin/EDTA dissociation reagent and incubate cells for 5–10 min at 37 °C. Control the cells under the microscope for detachment. <span style=color:blue>加入预热的1×胰蛋白酶/EDTA溶液，孵育细胞5–10分钟，观察细胞脱落情况。</span>
5. When ≥90% of the cells have detached, add pre-warmed complete growth medium to inactivate trypsin (volume at least equal to the volume used for the dissociation reagent). <span style=color:blue>当≥90%的细胞已脱落时，加入预热的完全生长培养基，终止胰蛋白酶的作用（其体积应至少与解离液相同）。</span>
6. Transfer cell suspension to a conical tube and centrifuge at 1000 × *g* for 5 min.<span style=color:blue>将细胞悬液转移至锥形管中，离心1000× *g* 5分钟。</span>
7. Aspirate the supernatant and resuspend cells in 10 mL pre-warmed complete growth medium. <span style=color:blue>吸去上清液，重悬细胞于10毫升预热的完全生长培养基中。</span>
8. Take a sample for counting and determine the total number of cells using a hemocytometer or cell counter.<span style=color:blue>取样并使用血球计数板或细胞计数器进行细胞计数。</span>
9. Dilute cell suspension to the appropriate seeding density , and move 1.5 × 10<sup>6</sup> cells into a new 75 cm<sup>2</sup> flask.<span style=color:blue>将细胞悬液稀释至所需的接种密度，移入1.5 × 10<sup>6</sup>个细胞的75 cm<sup>2</sup>新培养瓶中。</span>
10. Place the cells in a 37 °C incubator at 5% CO<sub>2</sub>. Monitor cell growth daily. <span style=color:blue>将细胞放入37°C、5% CO<sub>2</sub>的培养箱中，持续观察其生长情况。</span>

### 3.3 In Vitro Cellular Uptake of Fluorescent siRNA to Corneal Epithelial Cells 体外荧光siRNA在角膜上皮细胞中的摄取

1. Place coverslips in wells of 24-well plate. Sterilize under UV for 30 min. <span style=color:blue>将盖玻片放入24孔板的孔中，使用紫外线消毒30分钟。</span>
2. Seed 1 × 10<sup>5<sup> cells per well in 500 μL of DMEM GlutaMAX™ enriched with 10% FBS and grow the cells 24 h at standard culture conditions (*see* Subheading 3.2).<span style=color:blue>每孔接种1 × 10<suP>5</sup>个细胞，加入500μL的富含10%胎牛血清（FBS）的DMEM GlutaMAX™培养基，并在标准培养条件下培养24小时（*参见* 3.2小节）。</span>
3. Mix siGLO with tested formulation according to Table 2 to prepare samples of siRNA-carrier at optimized loading ratio (*see* Subheading 3.1) and incubate as required. Use Opti-MEM medium as diluent.<span style=color:blue>根据表2将siGLO与测试配方混合，准备siRNA-载体样品，按照优化的加载比例（*参见* 3.1小节）孵育。使用Opti-MEM培养基作为稀释剂。</span>
4. As a positive control, complex siGLO with Lipofectamine RNAiMAX transfection reagent according to Table 3, following manufacturer’s protocol.<span style=color:blue>作为阳性对照，将siGLO与Lipofectamine RNAiMAX转染试剂混合，按照表3中的厂家协议进行操作。</span>
5. As a negative control, prepare naked siRNA sample by diluting siGLO with Opti-MEM medium according to Table 4. <span style=color:blue>作为阴性对照，按照表4中的说明使用Opti-MEM培养基稀释siGLO，准备裸siRNA样品。</span>
6. Remove and discard 50 μL of growth medium from each well. <span style=color:blue>从每个孔中取出并丢弃50μL的生长培养基。</span>
7. Add 50 μL of above prepared siGLO solutions (**step 3**—tested sample, **step 4**—positive control and **step 5**—negative control) to separate wells (*see* **Note** **4**).<span style=color:blue>向每个孔中加入50μL上述准备的siGLO溶液（**步骤3**—测试样品，**步骤4**—阳性对照，**步骤5**—阴性对照）（*参见* **注释4**）。</span>
8. Incubate the cells for 24 h in an incubator at 37 °C with 5% CO<sub>2</sub> (*see* **Note** **5**). <span style=color:blue>在37°C，5% CO<sub>2</sub>的培养箱中孵育24小时（*参见* **注释5**）。</span>
9. After incubation, remove and discard medium from each well.<span style=color:blue>孵育结束后，从每个孔中移除并丢弃培养基。</span>
10. Wash the cells with phosphate-buffered saline (PBS) three times by adding 500 μL of PBS to each well and removing by aspiration.<span style=color:blue>用磷酸盐缓冲液（PBS）洗涤细胞三次，每次向每个孔中加入500μL PBS并通过吸取移除。</span>
11. Add 300 μL of 4% paraformaldehyde (PFA) to each well and incubate for 10 min at room temperature.<span style=color:blue>向每个孔中加入300μL的4%多聚甲醛（PFA），在室温下孵育10分钟。</span>
12. Remove and discard PFA solution. <span style=color:blue>移除并丢弃PFA溶液。</span>
13. Collect coverslips using forceps and mount them separately on a drop of mounting medium with DAPI placed on the microscope slide. Make sure that a coverslip is placed reversing side, so that cells are in contact with dye solution.<span style=color:blue>使用镊子收集盖玻片，并将其分别安装在载玻片上，滴加含DAPI的封片液。确保盖玻片反向放置，使细胞与染料溶液接触。</span>
14. Incubate the slides for 10 min in the dark.<span style=color:blue>在黑暗中孵育10分钟。</span>
15. Visualize the slides under fluorescence microscope. Measure green siGLO signal using FITC filter and compare with the image of cell nuclei acquired with DAPI filter. An example of imaging output is shown in Fig. 2.<span style=color:blue>在荧光显微镜下观察载玻片。使用FITC滤镜测量绿色siGLO信号，并与使用DAPI滤镜获取的细胞核图像进行比较。图2显示了成像输出示例。</span>

**Table 2** Example of reagent volumes (defined for one reaction) for preparation of fluorescent siGLO-carrier formulation for in vitro cellular uptake assay

| Component                                | Volume (single reaction) |
| :--------------------------------------- | :----------------------- |
| siGLO green transfection indicator, 5 μM | 5 μL                     |
| Tested carrier formulation               | 10 μL                    |
| Opti-MEM medium                          | 35 μL                    |

**Table 3** The reagent volumes (defined for one reaction) for preparation of positive control sample for in vitro cellular uptake assay

| Component                                | Volume (single reaction) |
| :--------------------------------------- | :----------------------- |
| siGLO green transfection Indicator, 5 μM | 5 μL                     |
| Lipofectamine RNAiMAX reagent            | 1.5 μL                   |
| Opti-MEM medium                          | 43.5 μL                  |

**Table 4** The reagent volumes (defined for one reaction) for preparation of negative control sample for in vitro cellular uptake assay

| Component                                | Volume (single reaction) |
| :--------------------------------------- | :----------------------- |
| siGLO green transfection indicator, 5 μM | 5 μL                     |
| Opti-MEM medium                          | 45 μL                    |

![485053_1_En_24_Fig2_HTML](C:\Users\User\Pictures\485053_1_En_24_Fig2_HTML.png)

**Fig. 2** Assessment of cellular uptake of siRNA to corneal epithelium cells in vitro. Fluorescent green siGLO (25 pmol) was transfected into HCE cells with Lipofectamine RNAiMAX (1.5 μL per 500 μL of growth medium). After 24 h, cells were washed with PBS, fixed with PFA, and stained with DAPI nuclear dye (blue)

### 3.4 In Vivo siRNA Uptake into Mouse Cornea

1. Initialize the IVIS .<span style=color:blue>启动IVIS系统。</span>
2. Anesthetize the mouse using 1.5–2% isoflurane in ~1.5 L/min flow of oxygen (setting 2.5 on isoflurane control valve).<span style=color:blue>使用1.5–2%的异氟烷在约1.5 L/min的氧气流量下麻醉小鼠（异氟烷控制阀设置为2.5）。</span>
3. Place the mouse inside the IVIS Spectrum imager chamber.<span style=color:blue>将小鼠放入IVIS Spectrum成像器的腔体中。</span>
4. Acquire image sequence according to the established protocol to measure fluorescence signal (*see* **Note** **6**).<span style=color:blue>根据已建立的协议获取图像序列以测量荧光信号（*参见* **注释6**）。</span>
5. Return the mouse safely to the home cage and control while it recovers consciousness.<span style=color:blue>安全地将小鼠返回其笼中，并在小鼠恢复意识时进行监控。</span>
6. Repeat fluorescence measurement with IVIS (**steps 1–5** above) on a daily frequency for 3 days prior to treatment using all experimental mice. Calculate ocular fluorescence baseline as an average signal intensity for right eye and left eye in separate.<span style=color:blue>在处理前的3天内，使用所有实验小鼠每天重复进行荧光测量（**步骤1–5**）。计算右眼和左眼的眼部荧光基线信号强度并分别记录。</span>
7. On the treatment day, mix siGLO with tested formulation to prepare eye drop samples of 25 μM siRNA-carrier at optimized conditions (*see* **Note** **7**). Also, dilute siGLO with the vehicle buffer to prepare control sample (25 μM naked siRNA).<span style=color:blue>在处理当天，将siGLO与测试配方混合，准备25μM siRNA-载体的眼药水样品，并在优化条件下进行配置（*参见* **注释7**）。同时，将siGLO与载体缓冲液稀释，准备对照样品（25μM裸siRNA）。</span>
8. Anesthetize the mouse and apply a 4 μL drop of siGLO-carrier on one eye of the animal and a 4 μL drop of naked siGLO control on the other eye of the animal (*see* **Note** **8**). Allow sample to absorb for 1 min.<span style=color:blue>麻醉小鼠，将4μL的siGLO-载体滴加至小鼠的一只眼睛，4μL裸siGLO对照滴加至另一只眼睛（*参见* **注释8**）。让样品吸收1分钟。</span>
9. Return the mouse safely to the home cage and control while it recovers consciousness.<span style=color:blue>安全地将小鼠返回其笼中，并在小鼠恢复意识时进行监控。</span>
10. Perform fluorescence measurement with IVIS (according to **steps 1–5** above) at least 3 h after the treatment (*see* **Note** **9**).<span style=color:blue>在治疗后至少3小时，使用IVIS系统（**步骤1–5**）进行荧光测量（*参见* **注释9**）。</span>
11. Compare posttreatment ocular fluorescence intensity with baseline measurements (from **step 6**) in separate for treated (i.e., siGLO-carrier) and control (i.e., naked siGLO) eye.<span style=color:blue>将治疗后眼部的荧光强度与基线测量值（**步骤6**）进行比较，分别记录治疗眼（即siGLO-载体）和对照眼（即裸siGLO）的荧光强度。</span>
12. After taking in vivo measurements, the fluorescence signal can be further examined in eye sections as explained below.<span style=color:blue>在进行体内测量后，可以进一步检查眼部切片中的荧光信号，具体方法如下。</span>
13. Euthanize the mice using carbon dioxide and gently enucleate the ocular globe from the sacrificed animal. Wash the enucleated eyes with phosphate-buffered saline to remove blood if required.<span style=color:blue>使用二氧化碳安乐死小鼠，并小心地从已安乐死的动物中摘除眼球。根据需要，用磷酸盐缓冲液洗涤摘除的眼球以去除血液。</span>
14. Collect the tissues into labeled tubes filled with 4% paraformaldehyde and fix for 2 h at room temperature.<span style=color:blue>将组织收集到标记的管中，加入4%多聚甲醛固定液，在室温下固定2小时。</span>
15. Transfer the collected tissues into tubes filled with phosphate-buffered saline to wash.<span style=color:blue>将收集到的组织转移到装有磷酸盐缓冲液的管中进行洗涤。</span>
16. Place the tissue for a few minutes in PolyFreeze in a labeled small weigh boat (to acclimate the tissue).<span style=color:blue>将组织放置在小称重船中，加入PolyFreeze，待组织适应。</span>
17. Transfer the tissue into fresh PolyFreeze in a labeled plastic cryomold (with just enough medium to cover the tissue) and orientate the eye with the cornea facing a side position allowing proper sectioning.<span style=color:blue>将组织转移至新鲜的PolyFreeze中，并将其放入标记的塑料冷冻模具中（足够的介质覆盖组织），将眼睛定位，使角膜朝向一侧，以便进行切片。</span>
18. Freeze prepared cryomold samples in slush of dry ice and isopentane in a metal container placed in a foam cooler and surrounded with crushed dry ice. Do not fully submerge the samples.<span style=color:blue>将准备好的冷冻模具样本置于干冰和异戊烯的冰浴中冷冻，并放置在泡沫冷却器中，周围填充碎干冰。请勿完全沉浸样品。</span>
19. Transfer frozen samples to a covered foam cooler filled with dry ice while continuing on to other samples. Wrap all samples in labeled foil and store at −80 °C until further processing.<span style=color:blue>将冷冻样本转移至覆盖的泡沫冷却器中，继续进行其他样本处理。将所有样本用标记好的铝箔包裹，并存储在-80°C直至进一步处理。</span>
20. Remove the frozen block from the freezer and allow it to equilibrate to temperature in the cryostat chamber for approximately 30 min.<span style=color:blue>从冰箱中取出冷冻样本，并让其在冷冻切片机室中平衡约30分钟。</span>
21. Perform a series of sections 5–10 μm thick using cryostat and collect sections on microscopy slides.<span style=color:blue>使用冷冻切片机切取5–10μm厚的切片，并将切片收集到显微镜载玻片上。</span>
22. Air-dry the slides at room temperature for 1 h.<span style=color:blue>在室温下让载玻片风干1小时。</span>
23. Add a drop of mounting medium with DAPI to cover each tissue section and place a coverslip on top.<span style=color:blue>向每个组织切片上滴加含DAPI的封片液，覆盖盖玻片。</span>
24. Incubate the slides for 10 min in the dark.<span style=color:blue>在黑暗中孵育10分钟。</span>
25. Visualize the slides under fluorescence microscope. Measure red siGLO signal using Cy5 filter and compare with the image of cell nuclei acquired with DAPI filter. An example of imaging output is shown in Fig. 3.<span style=color:blue>在荧光显微镜下观察载玻片，使用Cy5滤镜测量红色siGLO信号，并与使用DAPI滤镜获取的细胞核图像进行比较。图3显示了成像输出示例。</span>

![../images/485053_1_En_24_Chapter/485053_1_En_24_Fig3_HTML.png](https://raw.githubusercontent.com/zcgkiller/Pictures/main/Wechat/485053_1_En_24_Fig3_HTML.png)

**Fig. 3** Assessment of siRNA delivery to cornea cells in vivo. Formulation containing red fluorescent siGLO and naked siGLO control was applied topically onto mouse eye in a split body experiment. Live animal imaging was performed 3 h after administration using IVIS Spectrum and penetration of siGLO to the cornea was assessed in eye cross sections

## 4 Notes 注释

1. Use microwave on medium power for approximately 2 min but do not let the solution overflow when boiled. Heat with occasional stirring until solution is clear. Make sure the agarose is completely dissolved (no visible clumps in the solution). Remove the flask from the microwave with a glove and let it cool under tap water until you can comfortably pick it up without protection. <span style=color:blue>使用中等功率的微波炉加热约2分钟，但请注意不要让溶液在加热时溢出。加热时偶尔搅拌，直到溶液清澈为止。确保琼脂完全溶解（溶液中无可见的结块）。使用手套将烧瓶从微波炉中取出，并在水龙头下冷却，直到您可以舒适地拿起烧瓶而不需要保护。</span>
2. Loading ratio of siRNA to carrier can be expressed in multiple way, such as molar ratio (mol/mol), weight ratio (μg/μg), or commonly used N/P ratio, described as the ratio of positively charged amine (N = nitrogen) groups in a carrier system to negatively charged nucleic acid phosphate (P) groups. Thus, it depends on the investigator how to load siRNA onto carrier system. For a simple demonstration of sample preparation procedure at fixed siRNA concentration and at variable loading ratio, the increasing volume of carrier solution per volume unit of siRNA (v/v ratio) is used in the attached table. <span style=color:blue>siRNA与载体的加载比率可以通过多种方式表达，如摩尔比（mol/mol）、重量比（μg/μg），或常用的N/P比，即载体系统中带正电的氨基（N = 氮）与带负电的核酸磷酸（P）之间的比率。因此，如何将siRNA加载到载体系统上由研究人员决定。为了简单演示在固定siRNA浓度下、可变加载比率条件下的样品制备过程，附表中使用了每单位siRNA体积中载体溶液的递增体积（v/v比）。</span>
3. Various factors may have an effect on the process of siRNA complexation with the carrier system, such as type of siRNA-carrier interaction, loading ratio, temperature, physicochemical properties of the carrier, buffer composition, pH, and salt concentration. The procedure of siRNA loading requires optimization for each carrier system. Gel retardation assay described here is a method that may help to optimize loading ratio for a cationic carrier. <span style=color:blue>各种因素可能会影响siRNA与载体系统复合过程，如siRNA-载体相互作用类型、加载比率、温度、载体的物理化学性质、缓冲液成分、pH值和盐浓度。siRNA加载过程需要针对每个载体系统进行优化。这里描述的琼脂糖凝胶变速分析方法可以帮助优化阳离子载体的加载比率。</span>
4. Described procedure would result in 50 nM siGLO transfection using a single carrier/siRNA ratio of choice (based on previously performed gel retardation assay). However, it may be necessary to re-optimize siRNA delivery conditions for a certain carrier system in order to maximize transfection efficiency while minimizing cytotoxicity. It is a good practice to perform a screening study using triplicate wells containing siGLO at different concentrations (12.5, 25, 50, or 100 nM) and variable amount of carrier formulation per well.<span style=color:blue>描述的程序将导致使用单一载体/siRNA比率（基于先前进行的凝胶变速分析）获得50 nM siGLO转染。然而，可能需要重新优化siRNA的递送条件，以最大化转染效率并最小化细胞毒性。建议通过使用三重复孔，分别含有不同浓度的siGLO（12.5、25、50或100 nM）和可变载体配方的孔，进行筛选研究。</span>
5. The incubation time can be adjusted and the influence of the incubation time on cellular uptake of siRNA complexed with a certain carrier can be investigated. <span style=color:blue>孵育时间可以进行调整，并可以研究孵育时间对siRNA与特定载体复合物细胞摄取的影响。</span>
6. Signal acquisition protocol should be optimized for specific application. For siGLO Red detection epi-fluorescence measurement with 535 nm excitation filter and 580 nm emission filter at auto-exposure settings should be most suitable, although we recommend contacting IVIS Spectrum support team for protocol establishment.<span style=color:blue>信号采集协议应根据具体应用进行优化。对于siGLO Red的检测，建议使用535 nm激发滤镜和580 nm发射滤镜进行表面荧光测量，并使用自动曝光设置，但我们建议联系IVIS Spectrum支持团队来制定协议。</span>
7. Prior to advancing to in vivo studies, the formulation should be optimized for ophthalmic use. Most eye drops are sterile, isotonic, aqueous solutions that may contain excipients, which, for example, regulate osmotic pressure, the pH, and viscosity of the preparation. Moreover, the concentration of formulation should be optimized to enable sufficient siRNA dose to be applied within a limited volume of eye drop. Due to a low capacity of conjunctival sac, the volume between 2 and 5 μL should be used for topical installation to mouse eye.<span style=color:blue>在进入体内研究之前，应优化配方以供眼科使用。大多数眼药水是无菌的、等渗的水溶液，可能含有辅料，例如调节溶液的渗透压、pH值和粘度。此外，应优化配方的浓度，以确保在有限体积的眼药水中能够应用足够的siRNA剂量。由于结膜囊的容量较低，建议使用2至5μL的体积进行小鼠眼部的局部滴注。</span>
8. Following the implementation of the 3Rs, we recommend using a split body control experiment and compare the formulated siGLO in one eye (tested carrier) with a negative control of naked siGLO (vehicle) in the other eye of the same animal. The amount of siGLO administered shall be constant within the experiment, although the dose may require preliminary optimization.<span style=color:blue>在实施3Rs原则的基础上，建议进行分体对照实验，将配制好的siGLO滴加到一只眼睛（测试载体），同时在同一动物的另一只眼睛中使用裸siGLO（载体对照）。实验中的siGLO剂量应保持一致，尽管剂量可能需要初步优化。</span>
9. Due to the use of isoflurane for brief anesthesia throughout both topical administration and fluorescence measurement it is recommended to keep at least 3-h break between procedures.<span style=color:blue>由于使用异氟烷进行短暂麻醉进行局部滴注和荧光测量，建议在两项程序之间保持至少3小时的间隔。</span>